Literature DB >> 2158789

Ethanol and the NMDA receptor.

P L Hoffman1, C S Rabe, K A Grant, P Valverius, M Hudspith, B Tabakoff.   

Abstract

The actions of glutamate, the major excitatory amino acid in the CNS, are mediated by three receptor subtypes: kainate, quisqualate and N-methyl-D-aspartate (NMDA) receptors. Ethanol, in vitro, is a potent and selective inhibitor of the actions of agonists at the NMDA receptor. Following chronic ethanol ingestion, the number of NMDA receptor-ion channel complexes in certain brain areas is increased. This increase may contribute to the generation of ethanol withdrawal seizures, since administration of an NMDA receptor antagonist can reduce these seizures. The results suggest that certain acute behavioral effects of ethanol, such as effects on memory, as well as certain aspects of ethanol withdrawal, may involve the NMDA receptor.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2158789     DOI: 10.1016/0741-8329(90)90010-a

Source DB:  PubMed          Journal:  Alcohol        ISSN: 0741-8329            Impact factor:   2.405


  24 in total

Review 1.  Psychopharmacological properties of calcium channel inhibitors.

Authors:  O Pucilowski
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

2.  Repeated exposure to moderate doses of ethanol augments hippocampal glutamate neurotransmission by increasing release.

Authors:  Vladimir Chefer; Jennifer Meis; Grace Wang; Alexander Kuzmin; Georgy Bakalkin; Toni Shippenberg
Journal:  Addict Biol       Date:  2010-12-23       Impact factor: 4.280

3.  N-methyl-D-aspartate receptor antagonism has differential effects on alcohol craving and drinking in heavy drinkers.

Authors:  Suchitra Krishnan-Sarin; Stephanie S O'Malley; Nicholas Franco; Dana A Cavallo; Meghan Morean; Julia Shi; Brian Pittman; John H Krystal
Journal:  Alcohol Clin Exp Res       Date:  2015-02-09       Impact factor: 3.455

4.  Responding to acoustic startle during chronic ethanol intoxication and withdrawal.

Authors:  S Rassnick; G F Koob; M A Geyer
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

5.  Role of altered structure and function of NMDA receptors in development of alcohol dependence.

Authors:  József Nagy; Sándor Kolok; András Boros; Péter Dezso
Journal:  Curr Neuropharmacol       Date:  2005-10       Impact factor: 7.363

6.  Interaction of the NMDA receptor noncompetitive antagonist MK-801 with model and native membranes.

Authors:  J Moring; L A Niego; L M Ganley; M W Trumbore; L G Herbette
Journal:  Biophys J       Date:  1994-12       Impact factor: 4.033

7.  Short-term cognition deficits during early alcohol withdrawal are associated with elevated plasma homocysteine levels in patients with alcoholism.

Authors:  J Wilhelm; K Bayerlein; T Hillemacher; U Reulbach; H Frieling; B Kromolan; D Degner; J Kornhuber; S Bleich
Journal:  J Neural Transm (Vienna)       Date:  2005-07-06       Impact factor: 3.575

Review 8.  Pharmacotherapeutic management of co-morbid alcohol and opioid use.

Authors:  Lauren E Hood; Jonna M Leyrer-Jackson; M Foster Olive
Journal:  Expert Opin Pharmacother       Date:  2020-02-27       Impact factor: 3.889

Review 9.  Cholinergic mechanisms in physical dependence on barbiturates, ethanol and benzodiazepines.

Authors:  A Nordberg; G Wahlström
Journal:  J Neural Transm Gen Sect       Date:  1992

10.  Glutamate and benzodiazepine receptor autoradiography in rat brain after repetition of alcohol dependence.

Authors:  J Ulrichsen; B Bech; B Ebert; N H Diemer; P Allerup; R Hemmingsen
Journal:  Psychopharmacology (Berl)       Date:  1996-07       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.